Literature DB >> 19685351

Significant decrease in in-hospital mortality and major adverse cardiac events in Swiss STEMI patients between 2000 and December 2007.

Valérie Stolt Steiger1, Jean-Jacques Goy, Jean-Christophe Stauffer, Dragana Radovanovic, Nicole Duvoisin, Philip Urban, Osmund Bertel, Paul Erne.   

Abstract

OBJECTIVES: To evaluate the in-hospital outcome of STEMI (ST elevation myocardial infarction) patients admitted to Swiss hospitals between 2000 and December 2007, and to identify the predictors of in-hospital mortality and major cardiac events.
METHODS: Data from the Swiss national registry AMIS Plus (Acute Myocardial Infarction and Unstable Angina in Switzerland) were used. All patients admitted between January 2000 and December 2007 with STEMI or a new LBBB (left bundle branch block) were included in the registry. RESULT: We studied 12 026 STEMI patients admitted to 68 hospitals. The mean age was 64 +/- 13 years and 73% of the patients were male. Incidence of in-hospital death was 7.6% in 2000 and 6% in 2007. Reinfarction fell from 3.7% in 2000 to 0.9% in 2007. Thrombolysis decreased from 40.2% in 2000 to 2% in 2007. Clinical predictors of mortality were: age >65 years, Killips class III or IV, diabetes, Q wave myocardial infarction (at presentation). Patients undergoing percutaneous coronary intervention (PCI) had lower mortality and reinfarction rates (3.9% versus 11.2% and 1.1% versus 3.1% respectively, p <0.001) over time, although their numbers increased from 43% in 2000 to 85% in 2007. Patients admitted to hospitals with PCI facilities had lower mortality than patients hospitalised in hospitals without it, but the demographic characteristics differ widely between the two groups. Both in-hospital mortality and reinfarction decreased significantly over the time, parallel to an increased number of PCI. PCI was also the strongest predictor of survival.
CONCLUSION: In-hospital mortality and reinfarction rate have decreased significantly in Swiss STEMI patients in the last seven years, parallel to a significant increase in the number of percutaneous coronary interventions in addition to medical therapy. Outcome is not related to the site of admission but to PCI access.

Entities:  

Mesh:

Year:  2009        PMID: 19685351     DOI: smw-12607

Source DB:  PubMed          Journal:  Swiss Med Wkly        ISSN: 0036-7672            Impact factor:   2.193


  8 in total

1.  Euro Heart Survey 2009 Snapshot: regional variations in presentation and management of patients with AMI in 47 countries.

Authors:  Etienne Puymirat; Alex Battler; John Birkhead; Hector Bueno; Peter Clemmensen; Yves Cottin; Keith Aa Fox; Bulent Gorenek; Christian Hamm; Kurt Huber; Maddalena Lettino; Bertil Lindahl; Christian Müller; Alexander Parkhomenko; Susanna Price; Tom Quinn; Francois Schiele; Maarten Simoons; Gabriel Tatu-Chitoiu; Marco Tubaro; Christiaan Vrints; Doron Zahger; Uwe Zeymer; Nicolas Danchin
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2013-08-20

2.  Predictors of in-Hospital Mortality of ST-Segment Elevation Myocardial Infarction Patients Undergoing Interventional Treatment. An Analysis of Data from the RO-STEMI Registry.

Authors:  Diana E Cretu; Cristian A Udroiu; Claudiu I Stoicescu; Gabriel Tatu-Chitoiu; Dragos Vinereanu
Journal:  Maedica (Bucur)       Date:  2015-09

3.  Changes in treatment and mortality of acute myocardial infarction in Estonian tertiary and secondary care hospitals in 2001 and 2007.

Authors:  Mai Blöndal; Tiia Ainla; Toomas Marandi; Aleksei Baburin; Jaan Eha
Journal:  BMC Res Notes       Date:  2012-01-26

4.  Mortality Trends in Patients Hospitalized with the Initial Acute Myocardial Infarction in a Middle Eastern Country over 20 Years.

Authors:  Emad Ahmed; Jassim Al Suwaidi; Ayman El-Menyar; Hajar A H AlBinali; Rajvir Singh; A A Gehani
Journal:  Cardiol Res Pract       Date:  2014-04-28       Impact factor: 1.866

5.  Is coronary multivessel disease in acute myocardial infarction patients still associated with worse clinical outcomes at 1-year?

Authors:  Etienne Puymirat; Ariel Nakache; Christophe Saint Etienne; Pierre Marcollet; Olivier Fichaux; Marie-Pascale Decomis; Stephan Chassaing; Philippe Commeau; Nicolas Danchin; Guillaume Cayla; Gilles Montalescot; Hakim Benamer; Rene Koning; Pascal Motreff; Grégoire Rangé
Journal:  Clin Cardiol       Date:  2021-02-14       Impact factor: 3.287

6.  Changes in demographics, clinical practices and long-term outcomes of patients with ST segment-elevation myocardial infarction who underwent coronary revascularisation in the past two decades: cohort study.

Authors:  Yasuaki Takeji; Hiroki Shiomi; Takeshi Morimoto; Yusuke Yoshikawa; Ryoji Taniguchi; Yukiko Mutsumura-Nakano; Ko Yamamoto; Kyohei Yamaji; Junichi Tazaki; Eri Toda Kato; Hirotoshi Watanabe; Erika Yamamoto; Yugo Yamashita; Masayuki Fuki; Satoru Suwa; Moriaki Inoko; Teruki Takeda; Manabu Shirotani; Natsuhiko Ehara; Katsuhisa Ishii; Tsukasa Inada; Toshihiro Tamura; Tomoya Onodera; Eiji Shinoda; Takashi Yamamoto; Hiroki Watanabe; Hidenori Yaku; Kenji Nakatsuma; Hiroki Sakamoto; Kenji Ando; Yoshiharu Soga; Yutaka Furukawa; Yukihito Sato; Yoshihisa Nakagawa; Kazushige Kadota; Tatsuhiko Komiya; Kenji Minatoya; Takeshi Kimura
Journal:  BMJ Open       Date:  2021-03-31       Impact factor: 2.692

7.  Population specific and up to date cardiovascular risk charts can be efficiently obtained with record linkage of routine and observational data.

Authors:  David Faeh; Julia Braun; Kaspar Rufibach; Milo A Puhan; Pedro Marques-Vidal; Matthias Bopp
Journal:  PLoS One       Date:  2013-02-14       Impact factor: 3.240

8.  Trends in hospital discharges, management and in-hospital mortality from acute myocardial infarction in Switzerland between 1998 and 2008.

Authors:  Charlène Insam; Fred Paccaud; Pedro Marques-Vidal
Journal:  BMC Public Health       Date:  2013-03-25       Impact factor: 3.295

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.